UFP TECHNOLOGIES INC

UFP TECHNOLOGIES INCUFPTEarnings & Financial Report

Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.

UFPT Q4 FY2025 Key Financial Metrics

Revenue

$148.9M

Gross Profit

$42.0M

Operating Profit

$21.5M

Net Profit

$17.6M

Gross Margin

28.2%

Operating Margin

14.4%

Net Margin

11.8%

YoY Growth

3.4%

EPS

$2.22

UFP TECHNOLOGIES INC Q4 FY2025 Financial Summary

UFP TECHNOLOGIES INC reported revenue of $148.9M (up 3.4% YoY) for Q4 FY2025, with a net profit of $17.6M (up 7.3% YoY) (11.8% margin). Cost of goods sold was $106.9M, operating expenses totaled $20.5M.

Key Financial Metrics

Total Revenue$148.9M
Net Profit$17.6M
Gross Margin28.2%
Operating Margin14.4%
Report PeriodQ4 FY2025

Revenue Breakdown

UFP TECHNOLOGIES INC Q4 FY2025 revenue of $148.9M breaks down across 2 segments, led by Products at $145.1M (97.4% of total).

SegmentRevenue% of Total
Products$145.1M97.4%
Engineering And Development$1.8M1.2%

UFP TECHNOLOGIES INC Revenue by Segment — Quarterly Trend

UFP TECHNOLOGIES INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Engineering And Development) has evolved quarter over quarter.

SegmentQ4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025
Products$145.1M$149.3M$145.1M
Engineering And Development$1.8M$1.5M$1.6M

UFP TECHNOLOGIES INC Annual Revenue by Year

UFP TECHNOLOGIES INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $602.8M).

YearAnnual Revenue
2025$602.8Mvs 2024
2024$504.4Mvs 2023
2023$400.1Mvs 2022
2022$353.8M

UFP TECHNOLOGIES INC Quarterly Revenue & Net Profit History

UFP TECHNOLOGIES INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 FY2025$148.9M+3.4%$17.6M11.8%
Q3 FY2025$154.6M+6.5%$16.4M10.6%
Q2 FY2025$151.2M+37.2%$17.2M11.4%
Q1 FY2025$148.1M+41.1%$17.2M11.6%
Q4 FY2024$144.1M+41.9%$16.4M11.4%
Q3 FY2024$145.2M+44.0%$16.4M11.3%
Q2 FY2024$110.2M+10.1%$13.6M12.3%
Q1 FY2024$105.0M+7.4%$12.7M12.1%

Income Statement

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue$105.0M$110.2M$145.2M$144.1M$148.1M$151.2M$154.6M$148.9M
YoY Growth7.4%10.1%44.0%41.9%41.1%37.2%6.5%3.4%

Balance Sheet

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Assets$407.7M$422.4M$638.5M$629.0M$642.6M$634.7M$652.8M$655.1M
Liabilities$112.7M$112.2M$309.4M$286.2M$282.0M$249.2M$248.9M$231.2M
Equity$295.0M$310.2M$329.1M$342.8M$360.7M$385.5M$403.9M$423.9M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Operating CF$10.7M$11.7M$19.8M$24.4M$13.8M$25.3M$35.9M$16.8M